Skip to main content
HR 2427 108th Congress House Health Administrative procedure Commerce Congress Congressional reporting requirements Consumer protection Counterfeiting Crime and Law Enforcement Department of Health and Human Services Drug industry Drugs Foreign Trade and International Finance Government Operations and Politics Government paperwork Governmental investigations Identification devices Import restrictions Imports Labeling Law

Pharmaceutical Market Access Act of 2003

Introduced: June 11, 2003 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 16 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 25, 2003
On motion to recommit Failed by voice vote.
Jul 25, 2003
The previous question on the motion to recommit was ordered without objection.
Jul 25, 2003
Mr. Dingell moved to recommit to Energy and Commerce. (consideration: CR H7610; text: CR H7595-7596)
Jul 25, 2003
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jul 25, 2003
On passage Passed by recorded vote: 243 - 186 (Roll no. 445).
Jul 25, 2003
Motion to reconsider laid on the table Agreed to without objection.
Jul 25, 2003
Passed/agreed to in House: On passage Passed by recorded vote: 243 - 186 (Roll no. 445).
Jul 25, 2003
The previous question was ordered pursuant to the rule.
Jul 25, 2003
DEBATE - The House proceeded with one hour of debate on H.R. 2427.
Jul 25, 2003
Rule provides for consideration of H.R. 2427.
Jul 25, 2003
Considered under the provisions of rule H. Res. 335. (consideration: CR H7595-7611)
Jul 24, 2003
Rule H. Res. 335 passed House.
Jul 24, 2003
Rules Committee Resolution H. Res. 335 Reported to House. Rule provides for consideration of H.R. 2427.
Jun 24, 2003
Referred to the Subcommittee on Health.
Jun 11, 2003
Referred to the House Committee on Energy and Commerce.
Jun 11, 2003
Introduced in House
 Votes taken on this bill 1
DateChamberWhat was voted onResultYes–No
Jul 25, 2003 House · vote #445 On Passage Passed 243–186 See who voted →
 Plain-English summary Congressional Research Service

(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

Pharmaceutical Market Access Act of 2003 - (Sec. 4) Amends the Federal Food, Drug and Cosmetic Act to direct the Secretary of Health and Human Services to promulgate regulations allowing qualifying individuals to import covered products (in addition to pharmacists and wholesalers, whom current law authorizes to import such products).

Amends provision pertaining to record keeping regarding imported covered products. States that the Secretary shall not have to store records in cases in which qualifying individuals have imported a covered product.

Amends provisions regarding the importation of covered products, including to remove language directing the Secretary to require that a foreign seller specify the original source of the product and the amount of each lot of the product originally received.

Amends provisions regarding the testing of imported covered products. Declares that specified tests, including ones involving authenticity and degradation of products, shall not be required unless the importer is a wholesaler. Requires such tests to be conducted by the importer unless a product is a prescription drug subject to the provisions of this Act pertaining to counterfeit-resistant packaging. (Currently either the importer or the manufacturer may conduct such tests).

Eliminates the sunset date current law establishes for the provisions pertaining to the importation of covered products.

(Sec. 5) Classifies prescription drugs as misbranded if they do not incorporate specified counterfeit-resistant technologies in packaging.

What's happening now July 25, 2003

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Committees of jurisdiction 3
 Cosponsors 6
All 6 Democratic 3 Republican 2 Independent 1